(Q42695547)

English

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

scientific article published on 15 October 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Jiafu Ji

13

0 references

17

object named as

Yung-Jue Bang

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

9

object named as

Hoon-Kyo Kim

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Sung Hoon Noh

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sook Ryun Park

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Han-Kwang Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Hyun Cheol Chung

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ik-Joo Chung

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sang-Woon Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Hyung-Ho Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jin-Hyuk Choi

8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Wansik Yu

10

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jong Inn Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Dong Bok Shin

12

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jen-Shi Chen

14

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Yunni Lim

15

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Stella Ha

16

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

CLASSIC trial investigators

18

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

15 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1389-1396

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of the number of positive lymph nodes in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric Cancer Working Group Report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of oesophageal and gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nodal dissection for patients with gastric cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of initial recurrence in completely resected gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970473-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70473-5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42695547&oldid=1966251788"